Screener
Corcept Therapeutics CORT Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from Corcept Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
FAQ
- What is Corcept Therapeutics's net debt / EBITDA?
- Corcept Therapeutics (CORT) reported net debt / EBITDA of -12.2× in Q2 2026.
- How has Corcept Therapeutics's net debt / EBITDA changed year-over-year?
- Corcept Therapeutics's net debt / EBITDA decreased by 1206.7% year-over-year, from -0.9× to -12.2×.
- What is the long-term trend for Corcept Therapeutics's net debt / EBITDA?
- Over 5 years (2020 to 2025), Corcept Therapeutics's net debt / EBITDA has grown at a 34.5% compound annual growth rate (CAGR), from -0.6× to -2.5×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about Corcept Therapeutics's net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude